Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-012469
Filing Date
2024-02-07
Accepted
2024-02-07 21:23:48
Documents
2
Period of Report
2024-02-07

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 7788
2 EX-99.1 kytx-ex99_1.htm EX-99.1 14745
  Complete submission text file 0000950170-24-012469.txt   26462
Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 6175162878
Bain Capital Life Sciences Investors, LLC (Reporting) CIK: 0001703031 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41947 | Film No.: 24606595

Mailing Address 200 CLARENDON ST BOSTON MA 02116
Business Address 200 CLARENDON ST BOSTON MA 02116 16175162000
Bain Capital Life Sciences Fund III, L.P. (Reporting) CIK: 0001875273 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41947 | Film No.: 24606593

Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 6175162000
Bain Capital Life Sciences Opportunities III, LP (Reporting) CIK: 0001950105 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41947 | Film No.: 24606591

Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 6175162000
Bain Capital Life Sciences III General Partner, LLC (Reporting) CIK: 0001952106 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41947 | Film No.: 24606594

Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 6175162000
Bain Capital Life Sciences Opportunities III GP, LLC (Reporting) CIK: 0001964467 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41947 | Film No.: 24606592

Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 5106268331
Kyverna Therapeutics, Inc. (Issuer) CIK: 0001994702 (see all company filings)

EIN.: 831365441 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)